at Zacks.com (Nov 7, 2014)
Bio-Rad Labs (BIO +12.3%) shares surge after the company says it has extended its marketing deal with research tool maker Luminex (LMNX +0.2%). Under the deal, BIO will hold the worldwide sales and distribution rights to LMNX's Magpix multiplexing instrument.
From other sites
at Zacks.com (Oct 29, 2014)
at MarketWatch.com (Sep 29, 2011)